That may be so Salix, but that doesn't explain the low pps for a stock that shows such promise. Hopefully Wilson has a plan going forward that doesn't include massive dilution of the stock or putting TPIV in a position where the science is delayed or prevented from coming to market.
He has a huge responsibility, not only to investors, but moreso to millions of those that suffer from diseases now and in the future that TPIV products could prevent. I hope he understands this and not simply using this stock for his personal monetary playground.
News 
Market Data 
Discover 
